Truist Financial Boosts Omega Healthcare Investors (NYSE:OHI) Price Target to $33.00

Omega Healthcare Investors (NYSE:OHI) had its target price increased by Truist Financial from $32.00 to $33.00 in a research report report published on Wednesday morning, Benzinga reports. The firm currently has a hold rating on the real estate investment trust’s stock.

A number of other equities analysts also recently issued reports on the company. Wells Fargo & Company upgraded Omega Healthcare Investors to a strong-buy rating in a research report on Friday, June 14th. Citigroup upgraded Omega Healthcare Investors from a neutral rating to a buy rating and increased their price target for the stock from $32.00 to $35.00 in a research report on Friday, March 22nd. Finally, JMP Securities reiterated a market perform rating on shares of Omega Healthcare Investors in a research report on Monday, May 6th. Eight equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Omega Healthcare Investors has an average rating of Moderate Buy and an average price target of $33.71.

Omega Healthcare Investors Stock Up 0.6 %

Shares of OHI opened at $33.44 on Wednesday. Omega Healthcare Investors has a 52 week low of $27.53 and a 52 week high of $34.77. The company has a quick ratio of 6.68, a current ratio of 6.68 and a debt-to-equity ratio of 1.36. The company has a market capitalization of $8.26 billion, a price-to-earnings ratio of 30.12, a PEG ratio of 1.22 and a beta of 0.96. The stock’s 50-day moving average price is $31.47 and its 200-day moving average price is $30.90.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Tuesday, April 30th were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, April 29th. This represents a $2.68 annualized dividend and a dividend yield of 8.02%. Omega Healthcare Investors’s dividend payout ratio is presently 241.44%.

Institutional Investors Weigh In On Omega Healthcare Investors

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Pathway Financial Advisers LLC acquired a new stake in shares of Omega Healthcare Investors in the first quarter valued at approximately $2,825,000. Cetera Advisors LLC acquired a new stake in shares of Omega Healthcare Investors in the first quarter valued at approximately $646,000. Cetera Investment Advisers increased its holdings in shares of Omega Healthcare Investors by 170.6% in the first quarter. Cetera Investment Advisers now owns 97,866 shares of the real estate investment trust’s stock valued at $3,099,000 after purchasing an additional 61,700 shares during the last quarter. Highlander Capital Management LLC increased its holdings in shares of Omega Healthcare Investors by 52.0% in the first quarter. Highlander Capital Management LLC now owns 1,900 shares of the real estate investment trust’s stock valued at $60,000 after purchasing an additional 650 shares during the last quarter. Finally, Coppell Advisory Solutions Corp. acquired a new stake in shares of Omega Healthcare Investors in the first quarter valued at approximately $319,000. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.